Actualización en profundidad: desde las causas al tratamiento | 27 FEB 17

Revisión sobre enfermedad por reflujo gastroesofágico

La ERGE es una enfermedad altamente prevalente que conlleva una alteración significativa en la calidad de vida de los pacientes y altos costos en salud
Autor/a: Jorge A Olmos, María Marta Piskorz, Marcelo F Vela Acta Gastroenterol Latinoam 2016;46: 160-172
INDICE:  1. Página 1 | 2. Referencias bibliográficas
Referencias bibliográficas
  1. Dent J, Brun J, Fendrick AM, Fennerty MB, Janssens J, Kahrilas PJ, Lauritsen K, Reynolds JC, Shaw M, Talley NJ. An evidence-based appraisal of reflux disease management- the Genval Work­shop Report. Gut 1999; 44: S1-S16.
  2. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The Mon­treal definition and classification of gastroesophageal reflux disea­se: a global evidence-based consensus. Am J Gastroenterol 2006; 101: 1900-1920.
  3. Guyatt GH, Oxman AD, Kunz R, Jaeschke R, Helfand M, Li­berati A, Vist GE, Schünemann HJ, for the GRADE working group. Rating quality of evidence and strength of recommenda­tions: Incorporating considerations of resources use into grading recommendations. BMJ 2008; 336: 1170-1173.
  4. Katz P, Gerson L, Vela M. Guidelines for the Diagnosis and Ma­nagement of Gastroesophageal Reflux Disease. Am J Gastroente­rol 2013; 108: 308-328.
  5. Boeckxstaens G, El-Serag H, Smout A, Kahrilas P, Symptomatic reflux disease: the present, the past and the future. Gut 2014; 63: 1185-1193.
  6. A Barlow WJ, Orlando RC. The pathogenesis of heartburn in nonerosive reflux disease: a unifying hypothesis. Gastroenterology 2005; 128: 771-778.
  7. Sloan S, Rademaker AW, Kahrilas PJ. Determinants of gastroe­sophageal junction incompetence: hiatal hernia, lower esophageal sphincter, or both? Ann Intern Med 1992; 117: 977-982.
  8. Robertson EV, Derakhshan MH, Wirz AA. Central obesity in asymptomatic volunteers is associated with increased intrasphinc­teric acid reflux and lengthening of the cardiac mucosa. Gastroen­terology 2013; 145: 730-739.
  9. Lee YY, Wirz AA, Whiting JG, Robertson EV, Smith D, Weir A, Kelman AW, Derakhshan MH, McColl KE. Waist belt and central obesity cause partial hiatus hernia and short-segment acid reflux in asymptomatic volunteers. Gut 2014; 63: 1053-1060.
  10. Pandolfino JE, El-Serag HB, Zhang Q, Shah N, Ghosh SK, Kahrilas PJ. Obesity: a challenge to esophagogastric junction inte­grity. Gastroenterology 2006; 130: 639-649.
  11. Duggan C, Onstad L, Hardikar S. Association between markers of obesity and progression from Barrett’s esophagus to esophageal adenocarcinoma. Clin Gastroenterol Hepatol 2013; 11: 934-943.
  12. Gonlachanvit S, Maurer AH, Fisher RS, Parkman HP. Regional gastric emptying abnormalities in functional dyspepsia and gas­tro-oesophageal reflux disease. Neurogastroenterol Motil 2006; 18: 894-904.
  13. Fletcher J, Wirz A, Young J. Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal. Gastroentero­logy 2001; 121: 775-783.
  14. Beaumont H, Bennink RJ, de Jong J, Boeckxstaens GE.The po­sition of the acid pocket as a major risk factor for acidic reflux in healthy subjects and patients with GERD. Gut 2010; 59: 441-451.
  15. Kahrilas PJ, McColl K, Fox M, O’Rourke L, Sifrim D, Smout AJ, Boeckxstaens G. The acid pocket: a target for treatment in reflux disease. Am J Gastroenterol 2013; 108: 1058-1064.
  16. Hirschowitz BI. A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis. Gastroen­terology 1991; 101: 1149-1158.
  17. Vinjirayer E, González B, Brensinger C. Ineffective motility is not a marker for gastroesophageal reflux disease. Am J Gastroenterol 2003; 98: 771-776.
  18. Farré R. Pathophysiology of gastro-esophageal reflux disease: a role for mucosa integrity? Neurogastroenterol Motil 2013; 25: 783-799.
  19. Helm JF, Dodds WJ, Hogan WJ, Soergel KH, Egide MS, Wood CM. Acid neutralizing capacity of human saliva. Gastroenterolo­gy 1982; 83: 69-74.
  20. Sonnenberg A, Steinkamp U, Weise A, Berges W, Wienbeck M, Rohner HG, Peter P. Salivary secretion in reflux esophagitis. Gas­troenterology 1982; 83: 889-895.
  21. Gotley DC, Morgan AP, Cooper MJ. Bile acid concentrations in the ref­lux-ate of patients with reflux oesophagitis. Br J Surg 1988; 75: 587-590.
  22. Kauer WK, Peters JH, DeMeester TR, Feussner H, Ireland AP, Stein HJ, Siewert RJ. Composition and concentration of bile acid reflux into the esophagus of patients with gastro-esophageal reflux disease. Surgery 1997; 122: 874-881.
  23. Theisen J, Nehra D, Citron D. Suppression of gastric acid se­cretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids. J Gastrointest Surg 2000; 4: 50-54.
  24. Hopwood D, Milne G, Logan KR. Electron microscopic changes in human oesophageal epithelium in oesophagitis. J Pathol 1979; 129: 161-167.
  25. Tobey NA, Carson JL, Alkiek RA, Orlando RC. Dilated intercellu­lar spaces: a morphological feature of acid reflux–damaged human esophageal epithelium. Gastroenterology 1996; 111: 1200-1205.
  26. Caviglia R, Ribolsi M, Gentile M, Rabitti C, Emerenziani S, Guarino MP, Petitti T, Cicala M. Dilated intercellular spaces and acid reflux at the distal and proximal oesophagus in patients with non-erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2007; 25: 629-636.
  27. Neumann H, Mönkemüller K, Fry LC, Dombrowski F, Kuester D, Beyer M, Malfertheiner P. Intercellular space volume is mainly increased in the basal layer of esophageal squamous epithelium in patients with GERD. Dig Dis Sci 2011; 56: 1404-1411.
  28. Ribolsi M, Emerenziani S, Borrelli O, Balestrieri P, Addarii MC, Petitti T, Cicala M. Impedance baseline and reflux perception in responder and non-responder non-erosive reflux disease patients. Scand J Gastroenterol 2012; 47: 1266-1273.
  29. Borrelli O, Salvatore S, Mancini V. Relationship between baseli­ne impedance levels and esophageal mucosal integrity in children with erosive and non-erosive reflux disease. Neurogastroenterol Motil 2012; 24: 828–e394.
  30. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiolo­gy of gastro-oesophageal reflux disease: a systematic review. Gut 2005; 54: 710-717.
  31. Salis G. Revisión sistemática: epidemiología de la enfermedad por reflujo gastroesofágico en Latinoamérica. Acta Gastroenterol Lati­noam 2011; 41: 60-69.
  32. Chiocca JC, Olmos JA, Salis GB, Soifer LO, Higa R, Marcolongo M. Prevalence, clinical spectrum and atypical symptoms of gastro-oesophageal reflux in Argentina: a nationwide population-based study. Aliment Pharmacol Ther 2005; 22: 331-342.
  33. El Serag HB. Original article: Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2014; 63: 871-880.
  34. Olmos JA, Ramos RI, Argonz J, Lozzi RD, Higa R, Gadea O, Pe­rretta CJ, Caro LE, Cerisoli CL, Landoni NA, Salis G. Spectrum of endoscopic findings in patients with symptoms related to gas­troesophageal reflux disease (GERD) in Argentina. Nationwide epidemiological study. Gastroenterology 2009; 136: A489-A490.
  35. Thomson AB, Barkun AN, Armstrong D, Chiba N, White RJ, Daniels S, Escobedo S, Chakraborty B, Sinclair P, Van Zanten SJ. The prevalence of clinically significant endoscopic findings in pri­mary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment – Prompt Endoscopy (CA­DET–PE) study. Aliment Pharmacol Ther 2003; 17: 1481-1491.
  36. Francis D. High Economic Burden of Caring for Patients With Suspected Extraesophageal Reflux. Am J Gastroenterol 2013; 108: 905-911.
  37. Gerson LB, Kahrilas PJ, Fass R. Insights into gastroesophageal reflux disease-associated dyspeptic symptoms. Clin Gastroenterol Hepatol 2011; 9: 824-833.
  38. Olmos JA, Pogorelsky V, Tobal F, Marcolongo M, Salis G, Higa R, Chiocca JC. Uninvestigated dyspepsia in Latin América: a po­pulation based study. Dig Dis Sci 2006; 51: 1922-1929.
  39. Moayyedi P, Talley NJ, Fennerty MB. Can the clinical history distinguish between organic and functional dyspepsia? JAMA 2006; 295: 1566-1576.
  40. Numans ME, Lau J, de Wit NJ. Short-term treatment with pro­ton-pump inhibitors as a test for gastroesophageal reflux disease: a metaanalysis of diagnostic test characteristics. Ann Intern Med 2004; 140: 518-527.
  41. Johnston BT, Troshinsky MB, Castell JA, Castell DO. Compa­rison of barium radiology with esophageal pH monitoring in the diagnosis of gastroesophageal reflux disease. Am J Gastroenterol 1996; 91: 1181-1185.
  42. Richter JE, Castell DO. Gastroesophageal reflux. Pathogenesis, diagnosis, and therapy. Ann Intern Med 1982; 97: 93-103.
  43. Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmi­che JP, Johnson F, Hongo M, J E Richter JE, Spechler SJ, Tytgat GNJ, WallinL. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999; 45: 172-180.
  44. Johnsson F, Joelsson B, Gudmundsson K, Greiff L. Symptoms and endoscopic findings in the diagnosis of gastroesophageal ref­lux disease. Scand J Gastroenterol 1987; 22: 714-718.
  45. Takubo K, Honma N, Aryal G, Sawabe M, Arai T, Tanaka Y, Ma­fune K, Iwakiri K. Is there a set of histologic changes that are inva­riably reflux associated? Arch Pathol Lab Med 2005; 129: 159-163.
  46. Hirano I, Richter JE. ACG practice guidelines: esophageal reflux testing. Am J Gastroenterol 2007; 102: 668-685.
  47. Sifrim D, Castell D, Dent J, Kahrilas PJ. Gastroesophageal reflux monitoring: review and consensus report on detection and defini­tions of acid, non-acid, and gas reflux. Gut 2004; 53: 1024-1031.
  48. Duroux P, Bauerfeind P, Emde C, Koelz HR, Blum AL. Early din­ner reduces nocturnal gastric acidity. Gut 1989; 30: 1063-1067.
  49. Orr WC, Harnish MJ. Sleep-related gastro-oesophageal reflux: provocation with a late evening meal and treatment with acid suppression. Aliment Pharmacol Ther 1998; 12: 1033-1038.
  50. Jacobson BC, Somers SC, Fuchs CS, Kelly CP, Camargo CA Jr. Body-mass index and symptoms of gastroesophageal reflux in wo­men. N Engl J Med 2006; 354: 2340-2348.
  51. Gagne DJ, Dovec E, Urbandt JE. Laparoscopic revision of vertical banded gastroplasty to Roux-en-Y gastric bypass: outcomes of 105 patients. Surg Obes Relat Dis 2011; 7: 493-499.
  52. Cremonini F, Ziogas DC, Chang HY, Kokkotou E, Kelley JM, Conboy L, Kaptchuk TJ, Lembo AJ. Meta-analysis: the effects of placebo treatment on gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2010; 32: 29-42.
  53. Labenz J, Malfertheiner P. Treatment of uncomplicated reflux di­sease. World J Gastroenterol 2005; 11: 4291-4299.
  54. van Pinxteren B, Sigterman KE, Bonis P. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev: CD002095.
  55. Gralnek IM, Dulai GS, Fennerty MB, Spiegel BM. Esomepra­zole versus other proton pump inhibitors in erosive esophagitis: a meta-analysis of randomized clinical trials. Clin Gastroenterol Hepatol 2006; 4: 1452-1458.
  56. Metz DC, Vakily M, Dixit T. Review article: dual delayed release formulation of dexlansoprazole MR, a novel approach to over­come the limitations of conventional single release proton pump inhibitor therapy. Aliment Pharmacol Ther 2009; 29: 928-937.
  57. Fass R, , Inadomi J, Han C, Mody R, O’Neil J, Pérez MC. Main­tenance of Heartburn Relief After Step-Down from Twice-Daily Proton Pump Inhibitor to Once-Daily Dexlansoprazole Modified Release. Clin Gastroenterol and Hepatol 2012; 10: 247-253.
  58. Lind T, Havelund T, Lundell L, Glise H, Lauritsen K, Peder­sen SA, Anker-Hansen O, Stubberöd A, Eriksson G, Carlsson R, Junghard O. On demand therapy with omeprazole for the long-term management of patients with heartburn without oesopha­gitis–a placebo-controlled randomized trial. Aliment Pharmacol Ther 1999; 13: 907-914.
  59. Schindlbeck NE, Klauser AG, Berghammer G, Londong W, Mü­ller-Lissner SA. Three year follow up of patients with gastrooe­sophageal reflux disease. Gut 1992; 33: 1016-1019.
  60. Vigneri S, Termini R, Leandro G, Badalamenti S, Pantalena M, Savarino V, Di Mario F, Battaglia G, Mela GS, Pilotto A. A com­parison of five maintenance therapies for reflux esophagitis. N Engl J Med 1995; 333: 1106-1110.
  61. Fackler WK, Ours TM, Vaezi MF, Richter JE. Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough. Gas­troenterology 2002; 122: 625-632.
  62. Champion MC. Prokinetic therapy in gastroesophageal reflux d


Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2022